Moreover, we observed no discernible advantage of leflunomide in combination with IFN-α-2a on the duration of viral shedding in adult COVID-19 patients exhibiting prolonged polymerase chain reaction positivity (12). The gene discussed is IFNA2; the disease is COVID-19.